The Role of Microfluidics for Organ on Chip Simulations
AbstractA multichannel three-dimensional chip of a microfluidic cell culture which enables the simulation of organs is called an “organ on a chip” (OC). With the integration of many other technologies, OCs have been mimicking organs, substituting animal models, and diminishing the time and cost of experiments which is better than the preceding conventional in vitro models, which make them imperative tools for finding functional properties, pathological states, and developmental studies of organs. In this review, recent progress regarding microfluidic devices and their applications in cell cultures is discussed to explain the advantages and limitations of these systems. Microfluidics is not a solution but only an approach to create a controlled environment, however, other supporting technologies are needed, depending upon what is intended to be achieved. Microfluidic platforms can be integrated with additional technologies to enhance the organ on chip simulations. Besides, new directions and areas are mentioned for interested researchers in this field, and future challenges regarding the simulation of OCs are also discussed, which will make microfluidics more accurate and beneficial for biological applications. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Aziz, A.U.R.; Geng, C.; Fu, M.; Yu, X.; Qin, K.; Liu, B. The Role of Microfluidics for Organ on Chip Simulations. Bioengineering 2017, 4, 39.
Aziz AUR, Geng C, Fu M, Yu X, Qin K, Liu B. The Role of Microfluidics for Organ on Chip Simulations. Bioengineering. 2017; 4(2):39.Chicago/Turabian Style
Aziz, Aziz U.R.; Geng, Chunyang; Fu, Mengjie; Yu, Xiaohui; Qin, Kairong; Liu, Bo. 2017. "The Role of Microfluidics for Organ on Chip Simulations." Bioengineering 4, no. 2: 39.